| Name | Title | Contact Details |
|---|---|---|
Tom Kochy |
SVP, Head of Global Product Strategy and Commercial | Profile |
Rupert D`Souza |
Chief Financial Officer | Profile |
Christopher DeRespino |
Acting Chief Financial Officer and Chief Business Officer | Profile |
Leone Patterson |
President and Chief Financial Officer | Profile |
Jennifer DeBerardinis |
Vice President Procurement | Profile |
Solid Biosciences (Solid) is a life science company singularly focused on solving Duchenne muscular dystrophy (Duchenne). We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Cambridge, MA, USA.
Oxyband Technologies is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We build with carbon the same way nature does. Our biocement® materials are healthier for us and the Planet.
Alberta Conservation Association is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ignyta, located in San Diego, California, is a biotechnology company developing precision medicine with integrated Rx/Dx solutions for cancer patients. Its goal is to discover and develop revolutionary new drugs that target activated genes in cancer cells for the customized treatment of cancer patients. The company's present focus is on the development of RXDX-101, its proprietary oral tyrosine kinase inhibitor that targets solid tumor indications, and advancing its novel Spark discovery programs that leverage its proprietary cancer genomic and epigenomic knowledge bases